The challenges with developing therapeutic monoclonal antibodies for pandemic application

Expert Opin Drug Discov. 2022 Jan;17(1):5-8. doi: 10.1080/17460441.2021.1976141. Epub 2021 Sep 10.
No abstract available

Keywords: Epidemics; infectious diseases; monoclonal antibodies; pandemics; therapeutic antibodies.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents, Immunological*
  • COVID-19*
  • Humans
  • Pandemics
  • SARS-CoV-2

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents, Immunological